This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (78)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Echocardiography  • Arrhythmias  • Cardiac Diagnostic Tests  • Alert me on articles by topic

A Prospective Study of 1066 Patients From 3 Clinical Trials

Atrial Fibrillation Investigators: Atrial Fibrillation, Aspirin, Anticoagulation Study; European Atrial Fibrillation Study; Stroke Prevention in Atrial Fibrillation Study; Boston Area Anticoagulation Trial for Atrial Fibrillation Study; Canadian Atrial Fibrillation Study; Veterans Affairs Prevention in Atrial Fibrillation Study

Arch Intern Med. 1998;158:1316-1320.

Background  Clinical features that consistently predict ischemic stroke in patients with nonvalvular atrial fibrillation have been identified, while echocardiographic risk factors are less well defined.

Objective  To determine whether the results of transthoracic echocardiography add independent information to the clinical risk factors for stroke in patients with atrial fibrillation.

Methods  Transthoracic echocardiographic findings and clinical features from 1066 patients with atrial fibrillation assigned to placebo or control in 3 randomized trials (Boston Area Anticoagulation Trial for Atrial Fibrillation, Stroke Prevention in Atrial Fibrillation I Study, and Veterans Affairs Prevention in Atrial Fibrillation Study) were correlated with subsequent ischemic stroke by multivariate analysis.

Results  The mean±SD age of patients was 67±10 years, 78% were men, 55% had a history of hypertension, 19% had a history of diabetes, 7% had a previous transient ischemic attack or stroke, and 27% had a history of heart failure. During a mean follow-up of 1.6 years, 78 ischemic strokes occurred (annual rate, 4.7%). Moderate to severe left ventricular systolic dysfunction shown via 2-dimensional echocardiography was a strong independent predictor of stroke (relative risk, 2.5; P<.001) in the 1010 patients in whom echocardiographic values for left ventricular function were available. Left atrial diameter by M-mode echocardiography did not predict stroke (relative risk, 1.02/mm; P=.10). Of 163 patients categorized as low risk based on clinical features (annual stroke rate, 0.8%; 95% confidence interval, 0.2%-3.0%), 10 had moderate to severe left ventricular dysfunction shown via 2-dimensional echocardiography and a 9.3% per year risk of stroke (95% confidence interval, 1.3%-66%). Conversely, 728 of the 847 patients at high risk for stroke based on clinical criteria had normal or mildly abnormal left ventricular function; their stroke rate was 4.4% (95% confidence interval, 3.4%-5.8%).

Conclusions  Left ventricular systolic dysfunction shown via 2-dimensional transthoracic echocardiography independently predicts risk of stroke in patients with atrial fibrillation. Echocardiography may prove most useful in a small group of patients who have a low risk of stroke according to clinical factors.

This study was supported by grant R0124224 from the Division of Stroke and Trauma, National Institute of Neurological Disorders and Stroke, Bethesda, Md, and by a grant from DuPont-Merck Pharmaceuticals, Wilmington, Del.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke
Tayal et al.
Neurology 2008;71:1696-1701.
ABSTRACT | FULL TEXT  

Managing catheter ablation for atrial fibrillation: the role of echocardiography
Gabriel and Klein
Europace 2008;10:iii8-iii13.
ABSTRACT | FULL TEXT  

Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS2 score
Kleemann et al.
Eur J Echocardiogr 2008;0:jen256v1-6.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Singer et al.
Chest 2008;133:546S-592S.
ABSTRACT | FULL TEXT  

Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Salem et al.
Chest 2008;133:593S-629S.
ABSTRACT | FULL TEXT  

Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation
Stroke Risk in Atrial Fibrillation Working Group
Stroke 2008;39:1901-1910.
ABSTRACT | FULL TEXT  

Independent predictors of stroke in patients with atrial fibrillation: A systematic review
The Stroke Risk in Atrial Fibrillation Working Gro
Neurology 2007;69:546-554.
ABSTRACT | FULL TEXT  

Identification, diagnosis and assessment of atrial fibrillation
Dewar et al.
Heart 2007;93:25-28.
FULL TEXT  

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Writing Committee Members et al.
Europace 2006;8:651-745.
FULL TEXT  

Additive Role of Plasma von Willebrand Factor Levels to Clinical Factors for Risk Stratification of Patients With Atrial Fibrillation
Lip et al.
Stroke 2006;37:2294-2300.
ABSTRACT | FULL TEXT  

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
J Am Coll Cardiol 2006;48:e149-e246.
FULL TEXT  

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
Circulation 2006;114:e257-e354.
FULL TEXT  

Emerging Role of Direct Thrombin Inhibitors in Nonvalvular Atrial Fibrillation: Potential and Peril
Kim and Arora
J CARDIOVASC PHARMACOL THER 2005;10:11-21.
ABSTRACT  

Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin
Gage et al.
Circulation 2004;110:2287-2292.
ABSTRACT | FULL TEXT  

Prothrombotic Activity Is Increased in Patients With Nonvalvular Atrial Fibrillation and Risk Factors for Embolism
Inoue et al.
Chest 2004;126:687-692.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Singer et al.
Chest 2004;126:429S-456S.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy in Valvular Heart Disease--Native and Prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Salem et al.
Chest 2004;126:457S-482S.
ABSTRACT | FULL TEXT  

Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography
McNamara et al.
ANN INTERN MED 2003;139:1018-1033.
ABSTRACT | FULL TEXT  

The high incidence of left atrial appendage thrombosis in patients on maintenance haemodialysis
Nishimura et al.
Nephrol Dial Transplant 2003;18:2339-2347.
ABSTRACT | FULL TEXT  

A 60-Year-Old Woman With Atrial Fibrillation
Singer
JAMA 2003;290:2182-2189.
FULL TEXT  

A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community: The Framingham Heart Study
Wang et al.
JAMA 2003;290:1049-1056.
ABSTRACT | FULL TEXT  

Lessons from the Stroke Prevention in Atrial Fibrillation Trials
Hart et al.
ANN INTERN MED 2003;138:831-838.
ABSTRACT | FULL TEXT  

Atrial fibrillation and heart failure: natural history and pharmacological treatment
Savelieva and John Camm
Europace 2003;5:S5-S19.
ABSTRACT | FULL TEXT  

Thrombotic Disorders: Diagnosis and Treatment
Schafer et al.
ASH Education Book 2003;2003:520-539.
ABSTRACT | FULL TEXT  

Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation: An Individual Patient Meta-analysis
van Walraven et al.
JAMA 2002;288:2441-2448.
ABSTRACT | FULL TEXT  

Transoesophageal echocardiography in selecting patients for anticoagulation after ischaemic stroke or transient ischaemic attack
Strandberg et al.
J. Neurol. Neurosurg. Psychiatry 2002;73:29-33.
ABSTRACT | FULL TEXT  

Paroxysmal atrial fibrillation
Lip and Hee
QJM 2001;94:665-678.
ABSTRACT | FULL TEXT  

Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Eur Heart J 2001;22:1852-1923.
 

Anticoagulation and atrial fibrillation
CONWAY and LIP
Postgrad. Med. J. 2001;77:487-487.
FULL TEXT  

Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage et al.
JAMA 2001;285:2864-2870.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy in Atrial Fibrillation
Albers et al.
Chest 2001;119:194S-206S.
FULL TEXT  

Antithrombotic Therapy in Valvular Heart Disease
Salem et al.
Chest 2001;119:207S-219S.
FULL TEXT  

Safety of Discontinuation of Anticoagulation in Patients With Intracranial Hemorrhage at High Thromboembolic Risk
Phan et al.
Arch Neurol 2000;57:1710-1713.
ABSTRACT | FULL TEXT  

A European View on the North American Fifth Consensus on Antithrombotic Therapy
Verstraete et al.
Chest 2000;117:1755-1770.
ABSTRACT | FULL TEXT  

Warfarin for Stroke Prevention Still Underused in Atrial Fibrillation : Patterns of Omission
Cohen et al.
Stroke 2000;31:1217-1222.
ABSTRACT | FULL TEXT  

The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis Commentary: patients, preferences, and evidence
Protheroe et al.
BMJ 2000;320:1380-1384.
ABSTRACT | FULL TEXT  

Review: antithrombotic agents prevent stroke in non-valvular atrial fibrillation
Pullicino
Evid. Based Med. 2000;5:82-82.
FULL TEXT  

Assessment of risk of thromboembolism in atrial fibrillation: which patients should be anticoagulated?
Lip
Eur Heart J 1999;20:1757-1758.
 

Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation : Analysis of 2012 Participants in the SPAF I–III Clinical Trials
Hart et al.
Stroke 1999;30:1223-1229.
ABSTRACT | FULL TEXT  

Preventing Stroke in Patients With Atrial Fibrillation
Ezekowitz and Levine
JAMA 1999;281:1830-1835.
ABSTRACT | FULL TEXT  

Aortic Plaque in Atrial Fibrillation : Prevalence, Predictors, and Thromboembolic Implications
Blackshear et al.
Stroke 1999;30:834-840.
ABSTRACT | FULL TEXT  

LV Systolic Dysfunction Predicts Stroke in AF Patients
JWatch General 1998;1998:7-7.
FULL TEXT